Targeted breast cancer drug – olaparib – given green light by EU 16 Apr 2019 European Medicines Agency approves olaparib for women with BRCA-mutant breast cancer – 15 months after licensing in the US. Find out more Show/Hide
Precision drugs could unmask cancers to the immune system and boost the effects of immunotherapy 09 Mar 2019 Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals. Find out more Show/Hide
Key signalling protein linked to aggressive cancers 23 Jan 2019 Scientists have identified a protein which is associated with more aggressive breast, colorectal and ovarian cancers, which could be used to assist the diagnosis and development treatments for these cancers. Find out more Show/Hide
Practice-changing clinical trial reduces long-term radiotherapy side effects in women with breast cancer 21 Dec 2018
Fewer but larger radiation doses cause similarly low side-effects as conventional breast cancer radiotherapy 21 Oct 2018
ESMO 2018: Major trial shows targeted drug – palbociclib – extends breast cancer survival 20 Oct 2018
The ICR responds to the FDA approval of talazoparib for women with BRCA-mutant advanced breast cancer 18 Oct 2018